Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.19
(0.53%)
HKD 0.19
(0.53%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.06 Billion HKD | -14.47% |
| 2022 | 1.24 Billion HKD | 24.38% |
| 2021 | 999.73 Million HKD | -4.29% |
| 2020 | 1.04 Billion HKD | 22.72% |
| 2019 | 851.1 Million HKD | 8.57% |
| 2018 | 783.94 Million HKD | 21.1% |
| 2017 | 647.33 Million HKD | 17.14% |
| 2016 | 552.64 Million HKD | 4.04% |
| 2015 | 531.17 Million HKD | 20.97% |
| 2014 | 439.08 Million HKD | 533.63% |
| 2013 | 69.29 Million HKD | 8.83% |
| 2012 | 63.67 Million HKD | 150.39% |
| 2011 | 25.43 Million HKD | 89.59% |
| 2010 | 13.41 Million HKD | -86.18% |
| 2009 | 97.07 Million HKD | 200.44% |
| 2008 | 32.31 Million HKD | -96.16% |
| 2007 | 841.98 Million HKD | -2.25% |
| 2006 | 861.34 Million HKD | 22.63% |
| 2005 | 702.36 Million HKD | 8.01% |
| 2004 | 650.3 Million HKD | -13.74% |
| 2003 | 753.91 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 1.04 Billion HKD | 0.0% |
| 2023 Q1 | 1.04 Billion HKD | -15.63% |
| 2023 FY | 1.06 Billion HKD | -14.47% |
| 2023 Q4 | 1.06 Billion HKD | 0.0% |
| 2023 Q3 | 1.06 Billion HKD | 1.38% |
| 2022 FY | 1.24 Billion HKD | 24.38% |
| 2022 Q3 | 1.24 Billion HKD | 11.58% |
| 2022 Q4 | 1.24 Billion HKD | 0.0% |
| 2022 Q2 | 1.11 Billion HKD | 0.0% |
| 2022 Q1 | 1.11 Billion HKD | 11.47% |
| 2021 Q1 | 920.51 Million HKD | -11.87% |
| 2021 Q2 | 920.51 Million HKD | 0.0% |
| 2021 Q3 | 999.73 Million HKD | 8.61% |
| 2021 Q4 | 999.73 Million HKD | 0.0% |
| 2021 FY | 999.73 Million HKD | -4.29% |
| 2020 FY | 1.04 Billion HKD | 22.72% |
| 2020 Q4 | 1.04 Billion HKD | 0.0% |
| 2020 Q2 | 930.92 Million HKD | 0.0% |
| 2020 Q3 | 1.04 Billion HKD | 12.2% |
| 2020 Q1 | 930.92 Million HKD | 9.38% |
| 2019 Q4 | 851.1 Million HKD | 0.0% |
| 2019 Q2 | 901.42 Million HKD | -6.24% |
| 2019 FY | 851.1 Million HKD | 8.57% |
| 2019 Q1 | 961.42 Million HKD | 22.64% |
| 2019 Q3 | 851.1 Million HKD | -5.58% |
| 2018 Q2 | 714.82 Million HKD | 0.0% |
| 2018 Q3 | 783.94 Million HKD | 9.67% |
| 2018 Q4 | 783.94 Million HKD | 0.0% |
| 2018 FY | 783.94 Million HKD | 21.1% |
| 2018 Q1 | 714.82 Million HKD | 10.43% |
| 2017 Q4 | 647.33 Million HKD | 0.0% |
| 2017 Q3 | 647.33 Million HKD | 10.3% |
| 2017 Q2 | 586.88 Million HKD | 0.0% |
| 2017 Q1 | 586.88 Million HKD | 6.2% |
| 2017 FY | 647.33 Million HKD | 17.14% |
| 2016 Q3 | 552.64 Million HKD | 9.32% |
| 2016 Q4 | 552.64 Million HKD | 0.0% |
| 2016 Q1 | 505.54 Million HKD | -4.83% |
| 2016 FY | 552.64 Million HKD | 4.04% |
| 2016 Q2 | 505.54 Million HKD | 0.0% |
| 2015 Q2 | 452.59 Million HKD | 0.0% |
| 2015 Q3 | 531.17 Million HKD | 17.36% |
| 2015 Q4 | 531.17 Million HKD | 0.0% |
| 2015 Q1 | 452.59 Million HKD | 3.08% |
| 2015 FY | 531.17 Million HKD | 20.97% |
| 2014 Q3 | 439.08 Million HKD | -5.61% |
| 2014 FY | 439.08 Million HKD | 533.63% |
| 2014 Q1 | 465.2 Million HKD | 571.32% |
| 2014 Q4 | 439.08 Million HKD | 0.0% |
| 2014 Q2 | 465.2 Million HKD | 0.0% |
| 2013 Q3 | 67.3 Million HKD | 0.0% |
| 2013 Q4 | 69.29 Million HKD | 2.97% |
| 2013 FY | 69.29 Million HKD | 8.83% |
| 2013 Q1 | 63.67 Million HKD | 0.0% |
| 2013 Q2 | 67.3 Million HKD | 5.69% |
| 2012 FY | 63.67 Million HKD | 150.39% |
| 2012 Q2 | 37.15 Million HKD | 46.09% |
| 2012 Q1 | 25.43 Million HKD | 0.0% |
| 2012 Q3 | 37.15 Million HKD | 0.0% |
| 2012 Q4 | 63.67 Million HKD | 71.39% |
| 2011 FY | 25.43 Million HKD | 89.59% |
| 2011 Q3 | 13.94 Million HKD | 0.0% |
| 2011 Q1 | 13.41 Million HKD | 0.0% |
| 2010 Q3 | 19.9 Million HKD | 0.0% |
| 2010 Q1 | 97.07 Million HKD | 0.0% |
| 2010 FY | 13.41 Million HKD | -86.18% |
| 2009 FY | 97.07 Million HKD | 200.44% |
| 2008 FY | 32.31 Million HKD | -96.16% |
| 2007 FY | 841.98 Million HKD | -2.25% |
| 2006 FY | 861.34 Million HKD | 22.63% |
| 2005 FY | 702.36 Million HKD | 8.01% |
| 2004 FY | 650.3 Million HKD | -13.74% |
| 2003 FY | 753.91 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -245.256% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -874.869% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -500.53% |
| Huasheng International Holding Limited | 675.58 Million HKD | -57.433% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -1620.883% |
| Evergreen Products Group Limited | 786.46 Million HKD | -35.237% |
| EC Healthcare | 2.97 Billion HKD | 64.192% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | -37.769% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 34.258% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -517.391% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -2382.186% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -486.492% |